LONDON BROKER RATINGS: Deutsche Bank cuts Unilever and Britvic to Hold
LONDON BROKER RATINGS: Deutsche Bank cuts Unilever and Britvic to Hold
Read moreThu, 05th Aug 2021 10:45
LONDON BROKER RATINGS: Deutsche Bank cuts Unilever and Britvic to Hold
Read moreUK earnings, trading statements calendar - next 7 days
Read moreClinigen signs UK distribution deal for Paion hospital drugs
Read moreEXECUTIVE CHANGES: Next adds SEGRO CFO to board as non-exec director
Read more(Sharecast News) - Pharmaceutical products and services company Clinigen announced on Wednesday that non-executive director and chairman-designate Elmar Schnee was becoming chairman with immediate effect.
Read moreEXECUTIVE CHANGES: Clinigen CFO to depart, replacement search underway
Read more(Sharecast News) - Pharmaceutical group Clinigen said on Wednesday that chief financial officer Nick Keher has stepped down with immediate effect "to pursue other business interests".
Read moreClinigen partners with Eyevance to supply antifungal drug Natacyn
Read moreEXECUTIVE CHANGES: Clinigen taps new chair; essensys hires from WeWork
Read moreIN BRIEF: Clinigen to manage distribution of epilepsy drug Kigabeq
Read more(Sharecast News) - Carnival: Berenberg upgrades to hold with a target price of 1,400p.
Read moreClinigen expects annual revenue rise in transitional year
Read more(Sharecast News) - Pharmaceutical products and services company Clinigen updated the market on its just-ended financial year on Tuesday, saying net revenue was expected to be £455m, representing an increase of 12% on both a constant currency and organic basis.
Read more(Sharecast News) - The Sunday Times's Sabah Meddings told readers to 'hold' shares of Clinigen amid some resurgent 'market chatter' regarding a possible bid emerging for the medicines supplier.
Read more